Showing results (461-470 of 974) with videos related to
Sort By:
Pageof 98
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.Vaccines|July 27, 2024
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung CancerPhilip C Mack, Chih-Yuan Hsu, Ananda M Rodilla, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung CancerDavid E Gerber, William C Putnam, Farjana J Fattah, et al.Cancer Cell|December 14, 2016
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase InhibitorsXiumei Huang, Edward A Motea, Zachary R Moore, et al.Journal for Immunotherapy of Cancer|June 26, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse eventsJulie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, et al.Biorxiv : the Preprint Server for Biology|July 15, 2024
Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing DataBing Song, Kaiwen Wang, Saiyang Na, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian CancerDavid E Gerber, Jeffrey R Infante, Michael S Gordon, et al.Nature Cell Biology|August 1, 2022
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulationGao Guo, Ke Gong, Nicole Beckley, et al.The New England Journal of Medicine|September 29, 2015
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung CancerHossein Borghaei, Luis Paz-Ares, Leora Horn, et al.Pageof 98